Inspired to improve outcomes in pancreatic cancer

Pippa Corrie speaks to Natasha Galukande, Assistant Commissioning Editor. Dr Corrie undertook a PhD in anticancer drug development before qualifying in medicine at Oxford University (Oxford, UK) and training in medical oncology at the University of Birmingham (Birmingham, UK). Pippa is now a Consultant Medical Oncologist and University Associate Lecturer at Cambridge University Hospitals NHS Foundation Trust (Cambridge, UK). She is Clinical Director for Systemic Therapies in the Cancer Division at Addenbrooke’s Hospital (Cambridge, UK), which sees over 3000 new patients each year, and lead Oncologist for the pancreatic cancer service at Addenbrooke’s Hospital and across the Anglia Cancer Network. She is Deputy Director of the Cambridge Cancer Trials Centre (Cambridge, UK) and a member of the National Cancer Research Institute Pancreatic Cancer Clinical Studies Group. Her goal is to improve outcomes for patients with chemoresistant cancers through the conduct of clinical trials. Her specialist interests are pancreaticobiliary cancers and melanoma, researching mechanisms of response and resistance to anticancer drugs.